In contrast, in four out of six women with primary growth hormone resistance (Laron syndrome), chronic treatment (many months) with excessive doses (120–150 micrograms/kg/day) of recombinant human IGF-1, resulted in hyperandrogenism [104], perhaps reflecting a supraphysiological dose of IGF-I. Here, IGF1 is linked to hyperandrogenism.